The chemopreventive potential and anti-inflammatory activities of Korean black ginseng in colon26-M3.1 carcinoma cells and macrophages

Journal of the Korean Society for Applied Biological Chemistry

Volumn 53, Issue 1, 2010, Pages 101-105

  Kim, Ae Jung ^a   Kang, Shin Jyung ^b   Lee, Kyung Hee ^c   Lee, Myungsook ^d   Ha, Sang Do ^e   Cha, Youn Soo ^f   Kim, Sun Yeou ^c  

^a Hyejeon University   (South Korea)

^b Joongbu University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Sungshin Women's University   (South Korea)

^e Chung Ang University   (South Korea)

^f Chonbuk National University   (South Korea)

Author keywords

Black ginseng; Colon26 M3.1 carcinoma cells; Cytokines; White ginseng

Indexed keywords

PANAX GINSENG;

EID: 78549268396     PISSN: 17382203     EISSN: None     Source Type: Journal    
DOI: 10.3839/jksabc.2010.017     Document Type: Article

References (32)

1. Attele AS, Wu JA, and Yuan CS. (1998) Ginseng pharmacology: multiple constituents and multiple actions Biochem Pharmaco 58, 1685-1693.
2. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, and Forrester JS. (1990) Detection and localization of tumor necrosis factor in human atheroma Am J Cardiol 65, 297-302.
3. Chun SC, Jee SY, Lee SG, Park SJ, Lee JR, and Kim SC. (2007) Anti-inflammatory activity of the methanol extract of Moutan cortex in LPS-activated Raw264.7 cells. Evid Based Complement Alternat Med 4, 327-333.
4. Croft M. (2009) The role of TNF superfamily members in Tcell function and diseases. Nat Rev Immunol 9, 271-285.
5. Delgado AV, McManus AT, and Chambers JP. (2003) Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37, 355-361.
6. Fei XF, Wang BX, Tashiro S, Li TJ, Ma JS, and Ikejima T. (2002) Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol Sin 23, 315-322.
7. Fichtlscherer S, Rossig L, Breuer S, Vasa M, Dimmeler S, and Zeiher AM. (2001) Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 104, 3023-3025.
8. Gillis CN. (1997) Panax ginseng pharmacology: A nitric oxide link? Biochem Pharmacol 54, 1-8.
9. Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, and Mohr R. (1996) Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 28, 247-252.
10. Gurevitch J, Yuhas Y, Lifschitz-Mercer B, Berger E, and Paz Y. (1997) Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 30, 1544-1561.
11. Ha ES, Hwang SH, Shin KS, Yu KW, Lee KH, Choi JS, Park WM, and Yoon TJ. (2004) Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation. Arch Pharm Res 27, 217-224.
12. Hasegawa H, Sung JH, and Huh JD. (1997a) Ginseng intestinal bacteria metabolite IH901 as a new antimetastatic agent. Arch Pharm Res 20, 539-544.
13. Hasegawa H, Sung JH, Matsumiya S, and Uchiyama M. (1997b) Main ginsengsaponine metabolites formed by intestinal Prevotella oris in hydrolyzing saponines. Plant Med 63, 436-440.
14. Kang KS, Kim HY, Pyo JS, and Yokozawa T. (2006) Increase in the free radical scavenging activity of ginseng by heat-processing. Biol Pharm Bull 29, 750-754.
15. Keum YS, Han SS, Chun KS, Park KK, Park JH, and Lee SK. (2003) Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NFkappaB activation and tumor promotion. Mutat Res 523-524, 75-85.
16. Kim SI, Park JH, Ryu JH, Park JD, Lee YH, and Park JH(1996) Ginsenoside Rg5, a genuine dammarane glycoside from Korean red ginseng. Arch Pharm Res 19, 551-553.
17. Kim SW, Kwon HY, Chi DW, Shim JH, Park JD, and Lee YH. (2003) Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochem Pharmacol 65, 75-82.
18. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, and Park MK. (2000) Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 63, 1702-1704.
19. Lee JH, Shen GN, Kim EK, Shin JH, Myung CS, Oh HJ, Kim DH, Roh SS, Cho W, Seo YB, Park YJ, Kang CW, and Song GY. (2006) Preparation of black ginseng and its antitumor activity. Korean J Orient Physiol Pathol 20, 951-956.
20. Levine B, Kalman J, Mayer L, Fillit H, and Packer M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323, 236-241.
21. Manardi T, Kapoor S, and Bielory L. (2009) Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunological effects. J Allergy Clin Immunol 123, 286-295.
22. Maury CP and Teppo AM. (1989) Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Int Med 225, 333-336.
23. Nam KY. (2005) The comparative understanding between red ginseng and white ginseng. J Ginseng Research 29, 1-18.
24. O'Hara M, Kiefer D, Farrell K, and Kemper K. (1998) A review of 12 commonly used medicinal herbs. Arch Fam Med 7, 523-536.
25. Popovich DG and Kitts DD. (2002) Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 406, 1-8.
26. Seiler C, Pohl T, Billinger M, and Meier B. (2003) Tumor necrosis factor alpha concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function. Heart 89, 96-97.
27. Song GY, Oh HJ, Roh SS, Seo YB, Park YJ, and Myung CS. (2006) Effect of black ginseng on body weight and lipid profiles in male rats fed normal diets. Korean J Pharmacog 50, 381-385.
28. Squadrito F, Domenica A, Zingarelli B, Ioculano M, Calapai G, and Campo GM. (1993) Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury. Eur J Pharmacol 237, 223-230.
29. Tanigawa K, Craig RA, Stoolman LM, and Chang AE. (2000) Effects of tumor necrosis factor-alpha on the in vitro maturation of tumorreactive effector T cells. J Immunother 23, 528-35.
30. Wargovich MJ. (2001) Colon cancer chemoprevention with ginseng and other botanicals. J Korean Med Sci 16, S81-86.
31. Yoon TJ, Yoo YC, Choi OB, Do MS, Kang TB, Lee SW, Azuma I, and Kim JB. (1995) Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumour angiogenesis and metastasis of haematogenous and nonhaematogenous tumour cells in mice. Cancer Lett 20, 83-91.
32. Yun TK. (2003) Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523, 63-74.